Nitrous Oxide for Pain
(NONI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates how acute pain affects long-term memory and body responses, both with and without low-dose nitrous oxide (commonly known as laughing gas). Researchers will use MRI scans to observe brain activity during the trial. Participants will receive nitrous oxide and experience controlled, mild pain. This trial may suit individuals without chronic pain who can safely undergo MRI scans. As an Early Phase 1 trial, this research aims to understand how nitrous oxide affects the brain, offering participants a chance to contribute to groundbreaking scientific knowledge.
Will I have to stop taking my current medications?
The trial requires that you do not regularly take certain medications, including pain medications, antiepileptics, antidepressants, antipsychotics, antihistamines, anti-anxiety medications, stimulants, or sleep-aids. If you are taking any of these, you may need to stop before participating.
Is there any evidence suggesting that nitrous oxide is likely to be safe for humans?
Research has shown that nitrous oxide is generally safe for managing pain and has been used worldwide for many years, particularly during childbirth. Studies have found that it is safe and lacks the serious risks associated with other pain relief methods. A large study of over 22,000 patients found that nitrous oxide did not increase the risk of death or major complications after surgery. While it might not completely eliminate pain, its side effects are usually minor, making it a well-tolerated choice for many people.12345
Why do researchers think this study treatment might be promising?
Unlike the standard of care for pain relief, which often includes medications like opioids and NSAIDs that can have significant side effects and risk dependencies, nitrous oxide offers a unique approach. Researchers are excited about nitrous oxide because it provides rapid pain relief by acting directly on the nervous system, potentially reducing the need for drugs with more severe side effects. This gas has a long history of safe use in medical settings, like dental procedures, making it a promising alternative for managing acute pain with fewer complications.
What evidence suggests that nitrous oxide might be an effective treatment for pain?
Studies have shown that nitrous oxide reduces pain by blocking pain signals in the brain, providing relief similar to other pain treatments. Research indicates it is particularly helpful during labor, offering safe pain management for both mothers and babies. Some studies suggest that lower amounts of nitrous oxide can be as effective as higher amounts, with fewer side effects like dizziness and nausea. Although nitrous oxide is commonly used in dental procedures and childbirth, its use for treating sudden pain conditions remains under study. In this trial, participants will receive nitrous oxide alongside painful electric nerve stimulation to evaluate its effectiveness in managing acute pain.678910
Are You a Good Fit for This Trial?
This trial is for individuals experiencing amnesia or pain who can undergo two visits with no long-term follow-up. Specific eligibility details are not provided, but typically participants must be in good health and meet certain age and condition severity criteria.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline functional MRI scans without nitrous oxide to assess brain activity and connectivity
Treatment
Participants receive nitrous oxide and undergo functional MRI scans to assess the effects on pain processing and memory encoding
Follow-up
Participants are monitored for memory performance 24 hours after the learning experiment
What Are the Treatments Tested in This Trial?
Interventions
- Nitrous Oxide
Find a Clinic Near You
Who Is Running the Clinical Trial?
Keith M Vogt
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator